Search

Gary W. Counts

Examiner (ID: 6122, Phone: (571)272-0817 , Office: P/1678 )

Most Active Art Unit
1678
Art Unit(s)
1678, 1641, 1677
Total Applications
1270
Issued Applications
600
Pending Applications
185
Abandoned Applications
497

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14996263 [patent_doc_number] => 20190317089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => MULTI-ARRAY IMPEDIMETRIC BIOSENSORS FOR THE DETECTION OF CONCUSSION AND TRAUMATIC BRAIN INJURIES [patent_app_type] => utility [patent_app_number] => 16/467116 [patent_app_country] => US [patent_app_date] => 2017-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467116 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/467116
Multi-array impedimetric biosensors for the detection of concussion and traumatic brain injuries Dec 10, 2017 Issued
Array ( [id] => 15326911 [patent_doc_number] => 20200003785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => USE OF ANTI-UCHL1 IGG PLASMA CONCENTRATION FOR DIAGNOSING IDIOPATHIC STEROID SENSITIVE NEPHROTIC SYNDROME [patent_app_type] => utility [patent_app_number] => 16/465380 [patent_app_country] => US [patent_app_date] => 2017-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465380 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/465380
USE OF ANTI-UCHL1 IGG PLASMA CONCENTRATION FOR DIAGNOSING IDIOPATHIC STEROID SENSITIVE NEPHROTIC SYNDROME Nov 29, 2017 Abandoned
Array ( [id] => 16144019 [patent_doc_number] => 10705077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Method for detecting analyte concentration [patent_app_type] => utility [patent_app_number] => 15/826712 [patent_app_country] => US [patent_app_date] => 2017-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 7525 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15826712 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/826712
Method for detecting analyte concentration Nov 29, 2017 Issued
Array ( [id] => 15529513 [patent_doc_number] => 20200057062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => DIAGNOSTIC MARKER FOR PREDICTING EFFICACY OF RA DRUG AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/485068 [patent_app_country] => US [patent_app_date] => 2017-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5307 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485068 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/485068
DIAGNOSTIC MARKER FOR PREDICTING EFFICACY OF RA DRUG AND APPLICATION THEREOF Nov 14, 2017 Abandoned
Array ( [id] => 12733195 [patent_doc_number] => 20180136232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-17 [patent_title] => CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE [patent_app_type] => utility [patent_app_number] => 15/814200 [patent_app_country] => US [patent_app_date] => 2017-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15814200 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/814200
Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease Nov 14, 2017 Issued
Array ( [id] => 14899755 [patent_doc_number] => 20190293643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => Method for Predicting the Response of a Subject with an Autoimmune Disease to a B Cell-Targeting Therapy [patent_app_type] => utility [patent_app_number] => 16/348744 [patent_app_country] => US [patent_app_date] => 2017-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348744 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348744
Method for Predicting the Response of a Subject with an Autoimmune Disease to a B Cell-Targeting Therapy Nov 8, 2017 Abandoned
Array ( [id] => 12206952 [patent_doc_number] => 20180052179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'RISK ASSESSMENT FOR ANTIBIOTICS TREATMENT IN PATIENTS SUFFERING FROM PRIMARY NON-INFECTIOUS DISEASE BY DETERMINING THE LEVEL OF PROCALCITONIN' [patent_app_type] => utility [patent_app_number] => 15/804282 [patent_app_country] => US [patent_app_date] => 2017-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5099 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804282 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/804282
RISK ASSESSMENT FOR ANTIBIOTICS TREATMENT IN PATIENTS SUFFERING FROM PRIMARY NON-INFECTIOUS DISEASE BY DETERMINING THE LEVEL OF PROCALCITONIN Nov 5, 2017 Abandoned
Array ( [id] => 12220759 [patent_doc_number] => 20180059120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'METHODS AND APPARATUS FOR ASSESSMENT OF RISK FOR JOINT INJURY' [patent_app_type] => utility [patent_app_number] => 15/804615 [patent_app_country] => US [patent_app_date] => 2017-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11071 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804615 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/804615
Methods and apparatus for assessment of risk for joint injury Nov 5, 2017 Issued
Array ( [id] => 12710980 [patent_doc_number] => 20180128826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => METHOD FOR RE-USING TEST PROBE AND REAGENTS IN AN IMMUNOASSAY [patent_app_type] => utility [patent_app_number] => 15/802075 [patent_app_country] => US [patent_app_date] => 2017-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802075 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/802075
METHOD FOR RE-USING TEST PROBE AND REAGENTS IN AN IMMUNOASSAY Nov 1, 2017 Abandoned
Array ( [id] => 14329083 [patent_doc_number] => 10295552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Method for diagnosis of primary hyperaldosteronism [patent_app_type] => utility [patent_app_number] => 15/789433 [patent_app_country] => US [patent_app_date] => 2017-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17768 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15789433 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/789433
Method for diagnosis of primary hyperaldosteronism Oct 19, 2017 Issued
Array ( [id] => 14655631 [patent_doc_number] => 20190234944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => DEVICES AND METHODS TO REDUCE INTERFERING COMPOUNDS IN BIOLOGICAL SAMPLES [patent_app_type] => utility [patent_app_number] => 16/338807 [patent_app_country] => US [patent_app_date] => 2017-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/338807
DEVICES AND METHODS TO REDUCE INTERFERING COMPOUNDS IN BIOLOGICAL SAMPLES Oct 12, 2017 Abandoned
Array ( [id] => 15869071 [patent_doc_number] => 20200141939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => APPARATUS AND METHOD FOR DETECTING CANINE CANCER [patent_app_type] => utility [patent_app_number] => 16/337114 [patent_app_country] => US [patent_app_date] => 2017-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7155 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337114 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/337114
APPARATUS AND METHOD FOR DETECTING CANINE CANCER Oct 9, 2017 Abandoned
Array ( [id] => 16192128 [patent_doc_number] => 20200232977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => METHOD FOR REDUCING MEASUREMENT ERROR IN LATEX AGGLUTINATION IMMUNOASSAY [patent_app_type] => utility [patent_app_number] => 16/651872 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651872 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/651872
Method for reducing measurement error in latex agglutination immunoassay Sep 28, 2017 Issued
Array ( [id] => 14583975 [patent_doc_number] => 20190219596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => METHOD FOR THE DIAGNOSIS OF ACUTE PANCREATITIS (AP) BY DETECTION OF GLYCOPROTEIN 2 ISOFORM ALPHA (GP2A) [patent_app_type] => utility [patent_app_number] => 16/331608 [patent_app_country] => US [patent_app_date] => 2017-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331608 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331608
Method for the diagnosis of acute pancreatitis (AP) by detection of glycoprotein 2 isoform alpha (GP2A) Sep 25, 2017 Issued
Array ( [id] => 12241210 [patent_doc_number] => 20180074073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'Methods of Detecting Anti-Leptin Neutralizing Antibodies' [patent_app_type] => utility [patent_app_number] => 15/702719 [patent_app_country] => US [patent_app_date] => 2017-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6518 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15702719 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/702719
Methods of detecting anti-leptin neutralizing antibodies Sep 11, 2017 Issued
Array ( [id] => 15256463 [patent_doc_number] => 20190376965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => METHODS AND MATERIALS FOR IDENTIFYING AND TREATING AUTOIMMUNE GFAP ASTROCYTOPATHY [patent_app_type] => utility [patent_app_number] => 16/331853 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331853 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331853
Methods and materials for identifying and treating autoimmune GFAP astrocytopathy Sep 5, 2017 Issued
Array ( [id] => 12663877 [patent_doc_number] => 20180113125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => Analyte Detection [patent_app_type] => utility [patent_app_number] => 15/691271 [patent_app_country] => US [patent_app_date] => 2017-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691271 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/691271
Analyte Detection Aug 29, 2017 Abandoned
Array ( [id] => 12206945 [patent_doc_number] => 20180052171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'KITS FOR DETERMINING MALE FERTILITY BY MEASURING LEVELS OF A2V-ATPASE, G-CSF, MIP 1 ALPHA, MCP-1, AND METHODS AND KITS FOR IMPROVING REPRODUCTIVE OUTCOMES IN ARTIFICIAL INSEMINATION PROCEDURES' [patent_app_type] => utility [patent_app_number] => 15/691422 [patent_app_country] => US [patent_app_date] => 2017-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6591 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691422 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/691422
KITS FOR DETERMINING MALE FERTILITY BY MEASURING LEVELS OF A2V-ATPASE, G-CSF, MIP 1 ALPHA, MCP-1, AND METHODS AND KITS FOR IMPROVING REPRODUCTIVE OUTCOMES IN ARTIFICIAL INSEMINATION PROCEDURES Aug 29, 2017 Abandoned
Array ( [id] => 16674624 [patent_doc_number] => 20210063387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => MEANS AND METHOD FOR DETECTING ANALYTES BY MEANS OF MACROSCOPIC GRANULATE PARTICLES [patent_app_type] => utility [patent_app_number] => 16/641951 [patent_app_country] => US [patent_app_date] => 2017-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2519 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641951 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/641951
MEANS AND METHOD FOR DETECTING ANALYTES BY MEANS OF MACROSCOPIC GRANULATE PARTICLES Aug 25, 2017 Abandoned
Array ( [id] => 14667601 [patent_doc_number] => 10371696 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Multiparametric method for assessing immune system status [patent_app_type] => utility [patent_app_number] => 15/678994 [patent_app_country] => US [patent_app_date] => 2017-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7829 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678994 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/678994
Multiparametric method for assessing immune system status Aug 15, 2017 Issued
Menu